Methotrexate/misoprostol embryopathy: report of four cases resulting from failed medical abortion.
Adam MP, Manning MA, Beck AE, Kwan A, Enns GM, Clericuzio C, Hoyme HE.
Am J Med Genet A. 2003 Nov 15;123A(1):72-8. doi: 10.1002/ajmg.a.20503.
Early medical abortion by telemedicine in the United Kingdom: a costing analysis.
Hawkins JE, Glasier A, Hall S, Regan L; RCOG Telemedicine cost-effectiveness working group.
BJOG. 2022 May;129(6):969-975. doi: 10.1111/1471-0528.17033. Epub 2021 Dec 20.
Abortion Complications (Nursing).
Parks E, Martinez CL, Sapkota R.
2025 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Cesarean Scar Ectopic Pregnancy: The Lurking Danger in Post Cesarean Failed Medical Abortion.
Anant M, Paswan A, Jyoti C.
J Family Reprod Health. 2019 Dec;13(4):223-227.
15. Cluster Headache.
Lansbergen CS, Fronczek R, Wilbrink LA, Cohen SP, de Vos CC, Huygen FJPM.
Pain Pract. 2025 Jun;25(5):e70050. doi: 10.1111/papr.70050.
Failed early medical abortion: beware of the uterine scar!--Case report.
Shojai R, Roblin P, Boubli L.
Eur J Contracept Reprod Health Care. 2012 Jun;17(3):237-9. doi: 10.3109/13625187.2012.671386. Epub 2012 Apr 12.
Outcome of first trimester medical termination of pregnancy: definitions and management.
Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, Lubusky M, Saya L, Gemzell Danielsson K.
Eur J Contracept Reprod Health Care. 2018 Dec;23(6):451-457. doi: 10.1080/13625187.2018.1535058. Epub 2019 Jan 2.
Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
Raymond EG, Tan YL, Grant M, Benavides E, Reis M, Sacks DN, Hannum C, Frapp S, Weaver MA.
Contraception. 2018 Apr;97(4):324-328. doi: 10.1016/j.contraception.2017.12.004. Epub 2017 Dec 11.
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K, Lalitkumar S.
Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8.
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Ferguson I, Scott H.
J Obstet Gynaecol Can. 2020 Dec;42(12):1532-1542.e2. doi: 10.1016/j.jogc.2020.04.006. Epub 2020 Apr 27.
